ANTIBIOTX AS has a total of 13 patent applications. It decreased the IP activity by 42.0%. Its first patent ever was published in 2015. It filed its patents most often in United Kingdom, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and environmental technology are IGLOO ZONE CHILE S A, RxOMEG Therapeutics LLC and WASA MEDICALS AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 5 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Mexico | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Sommer Morten Otto Alexander | 5 |
#2 | Simon Daniel Jean Jacques | 3 |
#3 | Toft-Kehler Rasmus Vendler | 3 |
#4 | Delavenne Emilie Flora Aurore | 3 |
#5 | Thomas Rades | 2 |
#6 | Hanne Mørck Nielsen | 2 |
#7 | Toft-Kehler Rasmus | 2 |
#8 | Ping Li | 2 |
#9 | Camilla Hasling Frandsen | 2 |
#10 | Petra Alexandra Priemel | 2 |
Publication | Filing date | Title |
---|---|---|
GB201813876D0 | Treatment | |
GB201813317D0 | Novel antibacterial compounds | |
GB201805453D0 | Novel use | |
GB201713653D0 | Dosage regimen | |
GB201713650D0 | Treatment |